Wuxi Biologics (Cayman) Financial Overview
Wuxi Biologics (Cayman)'s market cap is currently $17.77B. The company's EPS TTM is $0.0779647; its P/E ratio is 29.25; Wuxi Biologics (Cayman) is scheduled to report earnings on August 19, 2025, and the estimated EPS forecast is $0.08. See an overview of income statement, balance sheet, and cash flow financials.
